Regulatory 2022-08-18 | Half-year report 2022: Strong results from Orviglance Food Effect Study PDF Presentation Webcast Excel
Regulatory 2022-05-11 | Quarterly Report Q1 2022: Strong Orviglance support from healthcare professionals PDF Presentation Webcast Excel
Regulatory 2022-05-05 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 5 May 2022 PDF Presentation Webcast Excel
Regulatory 2022-04-11 | Ascelia Pharma publishes Annual Report for 2021 PDF Presentation Webcast Excel
Regulatory 2022-04-05 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB PDF Presentation Webcast Excel
Regulatory 2022-03-31 | Number of shares and votes in Ascelia Pharma AB PDF Presentation Webcast Excel
Regulatory 2022-03-07 | Ascelia Pharma suspends clinical activities in Russia PDF Presentation Webcast Excel
Regulatory 2022-02-10 | Quarterly Report Q4 2021: Strong data for Orviglance vs. a gadolinium contrast agent PDF Presentation Webcast Excel
Regulatory 2021-11-30 | Nomination Committee appointed for AGM 2022 in Ascelia Pharma AB PDF Presentation Webcast Excel
Regulatory 2021-11-04 | Quarterly Report Q3 2021: Oncoral – entering clinical collaboration PDF Presentation Webcast Excel
Regulatory 2021-09-21 | Ascelia Pharma Signs Clinical Collaboration Agreement With Taiho Oncology, Inc. for the Development of Oncoral in Combination with LONSURF® PDF Presentation Webcast Excel
Regulatory 2021-08-19 | Quarterly Report Q2 2021: Preparing Oncoral for the next level PDF Presentation Webcast Excel
Regulatory 2021-08-18 | Covid-19 extends recruitment period of SPARKLE study PDF Presentation Webcast Excel
Regulatory 2021-05-12 | Quarterly Report Q1 2021: US office opened in preparation of launch PDF Presentation Webcast Excel
Regulatory 2021-05-05 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 5 May 2021 PDF Presentation Webcast Excel
Regulatory 2021-04-30 | Number of shares and votes in Ascelia Pharma AB PDF Presentation Webcast Excel
Regulatory 2021-04-15 | Ascelia Pharma AB publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm PDF Presentation Webcast Excel
Regulatory 2021-04-13 | Bulletin from the extraordinary general meeting in Ascelia Pharma AB PDF Presentation Webcast Excel
